Cited by 980Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsExtracellular vesicles in disease

The DOI matches its Crossref record; 160 of the 162 references it cites were found in a registry or an index.

Targeting drugs to tumours using cell membrane-coated nanoparticles

Fang, Ronnie H., Gao, Weiwei, Zhang, Liangfang·2023·Nature Reviews Clinical Oncology

Open this paper in CoChat — free account

Abstract

Traditional cancer therapeutics, such as chemotherapies, are often limited by their non-specific nature, causing harm to non-malignant tissues. Over the past several decades, nanomedicine researchers have sought to address this challenge by developing nanoscale platforms capable of more precisely delivering drug payloads. Cell membrane-coated nanoparticles (CNPs) are an emerging class of nanocarriers that have demonstrated considerable promise for biomedical applications. Consisting of a synthetic nanoparticulate core camouflaged by a layer of naturally derived cell membranes, CNPs are adept at operating within complex biological environments; depending on the type of cell membrane utilized, the resulting biomimetic nanoformulation is conferred with several properties typically associated with the source cell, including improved biocompatibility, immune evasion and tumour targeting. In comparison with traditional functionalization approaches, cell membrane coating provides a streamlined method for creating multifunctional and multi-antigenic nanoparticles. In this Review, we discuss the history and development of CNPs as well as how these platforms have been used for cancer therapy. The application of CNPs for drug delivery, phototherapy and immunotherapy will be described in detail. Translational efforts are currently under way and further research to address key areas of need will ultimately be required to facilitate the successful clinical adoption of CNPs.

Integrity signals

Registry

Crossref · 10.1038/s41571-022-00699-x

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodríguez-Torres, M. D. P., Acosta‐Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 7,038
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523

Show all 162 references

Research works printed but not linked: 1

McCarthy, E. F. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop. J. 26, 154–158 (2006).

Sorted by citations

The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641
Wnt/β-catenin-driven EMT regulation in human cancers
Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05099-7 · Cited by 321
Advances in nanoparticles in targeted drug delivery–A review
Islam, S., Ahmed, M. M. S., Islam, M. A., et al. (2025) · Results in Surfaces and Interfaces · doi:10.1016/j.rsurfi.2025.100529 · Cited by 250
Advances of medical nanorobots for future cancer treatments
Kong, X., Gao, P., Wang, J., Fang, Y., & Hwang, K. C. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01463-z · Cited by 260
“The high drug loading capacity, controlled drug release, and the ability to integrate diagnostic reagents have further expanded the scope of the application of nanogels [357].”
Background
Designing nanotheranostics with machine learning
Rao, L., Yuan, Y., Shen, X., Yu, G., & Chen, X. S. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01753-8 · Cited by 231
“An ideal clinical treatment usually requires precisely delivering the right type of therapy to the right place, thus achieving localized management of disease with minimal toxicity 4,8 .”
A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering
Krishnan, N., Jiang, Y., Zhou, J., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01533-w · Cited by 181
“In recent years, cell membrane-coated nanoparticles (CNPs) have shown promise for the diagnosis, treatment and prevention of disease 1,2 .”
Self-citation
Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis
Deng, R., Zhao, R., Zhang, Z., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adh9751 · Cited by 156
“Efforts are underway to translate cell membrane coating technology into clinical practice, particularly in indications such as cancer and infectious diseases, and substantial progress has been made toward clinical trials ( 61 ).”
Background
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Diao, L., & Liu, M. (2023) · Advanced Science · doi:10.1002/advs.202300121 · Cited by 161
Advances and Prospects in Integrated Nano-oncology
Jiang, J., Cui, X., Huang, Y., Yan, D., Wang, B., Yang, Z., Chen, M., Wang, J., Zhang, Y., Liu, G., et al. (2024) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2024.9290060 · Cited by 141
GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs
Ji, Q., Zhu, H., Qin, Y., Zhang, R., Wang, L., Zhang, E., Zhou, X., & Meng, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1329636 · Cited by 133
“…the past decade, researchers have attempted to construct a number of drug delivery systems with biological activities, such as ferritin nanocarriers, cell membrane-coated drug carriers, and activated protein nanoparticles (Liang et al., 2014; Lee et al., 2016; He et al., 2019; Fang et al., 2023).”
Background
Exploring and leveraging aggregation effects on reactive oxygen species generation in photodynamic therapy
Zhuang, Z., Li, J., Shen, P., Zhao, Z., & Tang, B. Z. (2024) · Aggregate · doi:10.1002/agt2.540 · Cited by 131
Advancing engineering design strategies for targeted cancer nanomedicine
Gomerdinger, V. F., Nabar, N., & Hammond, P. T. (2025) · Nature Reviews Cancer · doi:10.1038/s41568-025-00847-2 · Cited by 146
“Thus, cell coating technology offers a versatile approach for imparting stealth, targeting and immunomodulatory properties onto nanoparticles; current efforts focus on improving scalability, batch-to-batch variability and quality analysis to make clinical translation possible 179 .”
Influential
Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers
Gao, X. J., Ciura, K., Ma, Y., Mikołajczyk, A., Jagiełło, K., Wan, Y., Gao, Y., Zheng, J., Zhong, S., Puzyn, T., et al. (2024) · Advanced Materials · doi:10.1002/adma.202407793 · Cited by 127
Metal–Drug Coordination Nanoparticles and Hydrogels for Enhanced Delivery
Wong, K., Nie, Z., Wong, M., Wang, Y., & Liu, J. (2024) · Advanced Materials · doi:10.1002/adma.202404053 · Cited by 124
Advances and applications of nanoparticles in cancer therapy
Huang, X., He, T., Liang, X., Xiang, Z., Liu, C., Zhou, S., Luo, R., Bai, L., Kou, X., Li, X., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.67 · Cited by 130
Innovative utilization of cell membrane‐coated nanoparticles in precision cancer therapy
He, Y., Zhang, S., She, Y., Liu, Z., Zhu, Y., Cheng, Q., & Ji, X. (2024) · Exploration · doi:10.1002/exp.20230164 · Cited by 126
Engineering and Targeting Neutrophils for Cancer Therapy
Zhang, J., Gu, J., Wang, X., Ji, C., Yu, D., Wang, M., Pan, J., Santos, H. A., Zhang, H., & Zhang, X. (2024) · Advanced Materials · doi:10.1002/adma.202310318 · Cited by 116
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment
Han, X., Gong, C., Yang, Q., Zheng, K., Wang, Z., & Zhang, W. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s442877 · Cited by 116
“230 The resulting formulations inherit the specific functions of the respective membranes, and the newly synthesized hybrid membranes are endowed with the corresponding functions by adjusting the ratio of the source membranes to achieve the organic integration of multiple functions into the same…”
Background
Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights
Nienhaus, K., & Nienhaus, G. U. (2023) · Small · doi:10.1002/smll.202301663 · Cited by 114
NIR‐II Photoacoustic Imaging‐Guided Oxygen Delivery and Controlled Release Improves Photodynamic Therapy for Hepatocellular Carcinoma
Zeng, S., Chen, J., Gao, R., Chen, R., Xue, Q., Ren, Y., Liu, L., Tang, C., Hu, H., Zeng, N., et al. (2023) · Advanced Materials · doi:10.1002/adma.202308780 · Cited by 105
Polyethylene glycol immunogenicity in nanomedicine
Chen, Y., Su, Y.-C., & Roffler, S. R. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00321-6 · Cited by 118
Artificial Intelligence-Assisted Design of Nanomedicines for Breast Cancer Diagnosis and Therapy: Advances, Challenges, and Future Directions
Shirzad, M., Shaban, M., Mohammadzadeh, V., Rahdar, A., Fathi‐karkan, S., Hoseini, Z. S., Najafi, M., Kharaba, Z. J., & Aboudzadeh, M. A. (2025) · BioNanoScience · doi:10.1007/s12668-025-01980-w · Cited by 107
Engineered Living Materials for Advanced Diseases Therapy
Xue, D. Q., Wu, W. H., Pan, P., & Zhang, X. (2023) · Advanced Materials · doi:10.1002/adma.202304963 · Cited by 95
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Shao, X., Zhao, X., Wang, B., Fan, J., Wang, J., & An, H. (2025) · Theranostics · doi:10.7150/thno.103636 · Cited by 101
Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives
Shen, X., Pan, D., Gong, Q., Gu, Z., & Luo, K. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.017 · Cited by 96
“Cell membrane-encapsulated nanoparticles have become a novel class of nanocarriers with a core-shell structure [272].”
Background
Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier
Lim, S. H., Yee, G. T., & Khang, D. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s450853 · Cited by 99
“16,166 By combining NP-based strategies with other modalities, such as ultrasound-wave, magnetic field, or intranasal delivery, the synergistic effects can lead to improved drug penetration and therapeutic efficacy.”
Background
Advances and clinical challenges of mesenchymal stem cell therapy
Mei, R., Wan, Z., Yang, C., Shen, X., Wang, R., Zhang, H., Yang, R., Li, J., Song, Y., & Su, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1421854 · Cited by 96
Biomimetic design strategies for biomedical applications
Wei, X., Wang, Y., Liu, Y., Ji, K., Li, K., Wang, J., & Gu, Z. (2024) · Matter · doi:10.1016/j.matt.2023.12.030 · Cited by 96
Targeting the Ubiquitin–Proteasome System and Recent Advances in Cancer Therapy
Spano, D., & Catara, G. (2023) · Cells · doi:10.3390/cells13010029 · Cited by 86
“Another promising approach to targeted drug delivery is the use of cell membrane-coated nanoparticles (CNPs) [177], an emerging class of nanocarriers.”
Background
Lipid-based nanosystems: the next generation of cancer immune therapy
Cheng, Z., Fobian, S., Gurrieri, E., Amin, M., D’Agostino, V., Falahati, M., Zalba, S., Debets, R., Garrido, M. J., Saeed, M., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01574-1 · Cited by 95
“CMCNs may confer biocompatibility, immune-cell co-operation, targeting, and prolonged systemic circulation to lipid-based NPs by integrating cell membrane portions into or onto NPs or surfaces thereof [38, 329].”
Background
Bone-targeted biomimetic nanogels Re-establish osteoblast/osteoclast balance to treat postmenopausal osteoporosis
Cui, Y., Lv, B., Li, Z., Ma, C., Gui, Z., Geng, Y., Liu, G., Sang, L., Xu, C., Min, Q., et al. (2024) · Small · doi:10.1002/smll.202303494 · Cited by 81
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Desai, N., Chavda, V. P., Singh, T. R. R., Thorat, N. D., & Vora, L. K. (2024) · Small · doi:10.1002/smll.202401631 · Cited by 83
Engineered Cell Membrane Coating Technologies for Biomedical Applications: From Nanoscale to Macroscale
An, Y., Ji, C., Zhang, H., Jiang, Q., Maitz, M. F., Pan, J., Luo, R., & Wang, Y. (2025) · ACS Nano · doi:10.1021/acsnano.4c16280 · Cited by 82
Supramolecularly Engineered Conjugate of Bacteria and Cell Membrane‐Coated Magnetic Nanoparticles for Enhanced Ferroptosis and Immunotherapy of Tumors
Xie, B., Zhao, H., Ding, Y., Wang, Z., Cheng, G., Li, S., Zhang, K., Ip, S. W., Yu, H., & Wang, R. (2023) · Advanced Science · doi:10.1002/advs.202304407 · Cited by 80
mRNA Cancer Vaccines: Construction and Boosting Strategies
Liu, X., Huang, P., Yang, R., & Deng, H. (2023) · ACS Nano · doi:10.1021/acsnano.3c05635 · Cited by 79
Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1
Yang, Z., Liu, X., Zhu, J., Chai, Y., Cong, B., Li, B., Gao, W.-F., Hu, Y., Wen, M., Liu, Y., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.11.008 · Cited by 83
Self-citation
Cell Membrane as A Promising Therapeutic Target: From Materials Design to Biomedical Applications
Wu, X., Hu, J., & Yoon, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202400249 · Cited by 79
Photoresponsive Drug Delivery Systems: Challenges and Progress
Yang, Y., Long, K., Chu, Y., Lu, H., Wang, W., & Zhan, C. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402975 · Cited by 77
Covalent Organic Frameworks: Opportunities for Rational Materials Design in Cancer Therapy
Zhou, L., Guan, Q., & Dong, Y. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202314763 · Cited by 73
Plant-derived exosome-like nanovesicles: A novel nanotool for disease therapy
Jin, Z., Na, J., Lin, X., Jiao, R., Liu, X., & Huang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30630 · Cited by 72
“This integration retains the original biological characteristics of PELNVs and greatly enhances their drug-loading capacity [89,90].”
Background
Surface Engineering of Nanoparticles toward Cancer Theranostics
Huang, P., Wang, C., Deng, H., et al. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00122 · Cited by 69
An Engineered Bionic Nanoparticle Sponge as a Cytokine Trap and Reactive Oxygen Species Scavenger to Relieve Disc Degeneration and Discogenic Pain
Yang, W., Li, K., Pan, Q. L., Huang, W., Xiao, Y., Lin, H., Liu, S., Chen, X., Lv, X., Feng, S., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c08097 · Cited by 69
Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy
Li, Z., Zhang, Q., Li, Z., Ren, L. F., Pan, D., Gong, Q., Gu, Z., Cai, H., & Luo, K. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.02.006 · Cited by 70
“The branched polymers-derived nanostructures could be endowed with a homologous targeting ability after they are coated with tumor cell membranes to form biomimetic nanoparticles, thereby improving their homologous recognition by tumor cells 22,23 .”
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Yang, M., Zhou, J., Lu, L., Deng, D., Huang, J., Tang, Z., Shi, X., Lo, P., Lovell, J. F., Zheng, Y., et al. (2024) · Exploration · doi:10.1002/exp.20230171 · Cited by 74
Cell membrane‐coated nanoparticles for the treatment of cancer
Krishnan, N., Fang, R. H., & Zhang, L. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1285 · Cited by 68
Self-citation
Machine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery
Wang, Q., Liu, Y., Li, C., Xu, S., Xu, S., & Liu, B. (2025) · Advanced Science · doi:10.1002/advs.202503138 · Cited by 81
Multiple Synergistic Effects of the Microglia Membrane-Bionic Nanoplatform on Mediate Tumor Microenvironment Remodeling to Amplify Glioblastoma Immunotherapy
Fan, Q., Kuang, L., Wang, F., Yin, Y., Dong, Z., Tian, N., Wang, J., Yin, T., & Wang, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c01253 · Cited by 66
Biomimetic Tumor Cell Membrane‐Encapsulated Nanoparticles Combine NIR‐II Photothermal Therapy and Chemotherapy for Enhanced Immunotherapy in Triple‐Negative Breast Cancer
Xiong, W., Cheng, Z., Chen, H., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202410841 · Cited by 64
Microneedle‐assisted transdermal delivery of nanoparticles: Recent insights and prospects
Guillot, A. J., Martínez‐Navarrete, M., Zinchuk‐Mironova, V., & Melero, A. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1884 · Cited by 64
Bioinspired Sonodynamic Nano Spray Accelerates Infected Wound Healing via Targeting and Disturbing Bacterial Metabolism
Qian, X., Lu, T., Huang, C., Zheng, D., Gong, G., Chu, X., Wang, X., Lai, H., Ma, L., Jiang, L., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202315576 · Cited by 63
Exosome-based nanoparticles and cancer immunotherapy
Ye, J., Li, D., Jie, Y., Luo, H., Zhang, W., & Qiu, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117296 · Cited by 67
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
Cheng, Q., Kang, Y., Yao, B. W., Dong, J., Zhu, Y., He, Y., & Ji, X. (2023) · Advanced Science · doi:10.1002/advs.202302131 · Cited by 60
Bioengineered nanotechnology for nucleic acid delivery
Zhang, Y., Luo, J., Gui, X., Zheng, Y., Schaar, E., Liu, G., & Shi, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.034 · Cited by 65
Advances in Lipid-Polymer Hybrid Nanoparticles: Design Strategies, Functionalization, Oncological and Non-Oncological Clinical Prospects
Jacob, S., Varkey, N. R., Boddu, S. H. S., Gorain, B., Rao, R., & Nair, A. B. (2025) · Pharmaceuticals · doi:10.3390/ph18121772 · Cited by 73
“Similarly, biomimetic nanocarriers including cell membrane-coated nanoparticles and extracellular vesicle inspired hybrids offer superior immune evasion and prolonged circulation relative to conventional LPHNPs [196].”
Cancer Cell Membrane Nanodiscs for Antitumor Vaccination
Guo, Z., Noh, I., Zhu, A. T., Yu, Y., Gao, W., Fang, R. H., & Zhang, L. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c01775 · Cited by 60
Self-citation
Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications
Yu, Y., Peng, Y., Shen, W., Zhou, Z., Kai, M., Gao, W., & Zhang, L. (2024) · Small Structures · doi:10.1002/sstr.202300473 · Cited by 61
Self-citation
Recent advances of engineering cell membranes for nanomedicine delivery across the blood–brain barrier
Yuan, S., Hu, D., Gao, D., Butch, C. J., Wang, Y., Zheng, H., & Sheng, Z. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03572-y · Cited by 70
“In contrast, membrane extraction from nucleated cells—such as tumor cells, macrophages, NK cells, and neutrophils—requires gradient centrifugation following cell lysis and homogenization [19].”
Influential
Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy
Zhong, Z., Deng, W., Wu, J., Shang, H., Tong, Y., Yu, H., Huang, Q., Ba, X., Chen, Z., & Tang, K. (2024) · Nanoscale · doi:10.1039/d4nr00284a · Cited by 65
A Twindrive Precise Delivery System of Platelet-Neutrophil Hybrid Membrane Regulates Macrophage Combined with CD47 Blocking for Postoperative Immunotherapy
Sheng, S., Jin, L., Zhang, Y., Sun, W., Mei, L., Zhu, D., Dong, X., & Lv, F. (2024) · ACS Nano · doi:10.1021/acsnano.3c10862 · Cited by 61
Neutrophil‐Mimetic, ROS Responsive, and Oxygen Generating Nanovesicles for Targeted Interventions of Refractory Rheumatoid Arthritis
Tang, Z., Meng, S., Yang, X., Xiao, Y., Wang, W., Liu, Y., Wu, K., Zhang, X., Guo, H., Zhu, Y. Z., et al. (2023) · Small · doi:10.1002/smll.202307379 · Cited by 58
Platelet-derived drug delivery systems: Pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond
Zhu, Y., Xu, L., Kang, Y., Cheng, Q., He, Y., & Ji, X. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122478 · Cited by 59
Spleen-targeted delivery systems and strategies for spleen-related diseases
Huang, Z., Sun, K., Luo, Z., Zhang, J., Zhou, H., Yin, H., Liang, Z., & You, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.007 · Cited by 56
A Homing Peptide Modified Neutrophil Membrane Biomimetic Nanoparticles in Response to ROS/inflammatory Microenvironment for Precise Targeting Treatment of Ischemic Stroke
Dong, Z., Tang, L., Zhang, Y., Ma, X., Yin, Y., Kuang, L., Fan, Q., Wang, F., Hu, X., Yin, T., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202309167 · Cited by 57
Homologous Tumor Targeting Molybdenum‐Doped Prussian Blue for Enhancing Immunotherapy via PTT/CDT and Remodeled Tumor Immune Microenvironment
Ma, S., Li, D., Jia, X., Xu, W., Ding, G., He, J., & Wang, J. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402692 · Cited by 57
Targeted ROS Scavenging for Disease Therapies Using Nanomaterials
Zhang, Y., Zhang, Y., Liang, R., Zou, J., Pei, R., & Chen, X. S. (2025) · Advanced Materials · doi:10.1002/adma.202504435 · Cited by 64
Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review
Zhou, Z., Wang, H., Li, J., Jiang, X., Li, Z., & Shen, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127911 · Cited by 54
Cell membrane-based biomimetic technology for cancer phototherapy: Mechanisms, recent advances and perspectives
Li, S., Meng, X., Peng, B., Huang, J., Liu, J., Xiao, H., Li, M., Liu, Y., & Tang, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.11.029 · Cited by 56
Surface engineering of nanoparticles for precision medicine
Zheng, J., Sun, Y., Shen, Y., & Zhou, Z. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100037 · Cited by 55
Genetically engineered cellular nanoparticles for biomedical applications
Krishnan, N., Peng, F.-X., Mohapatra, A., Fang, R. H., & Zhang, L. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122065 · Cited by 56
Self-citation
In situ formed scaffold with royal jelly-derived extracellular vesicles for wound healing
Tan, D., Zhu, W., Liu, L., Pan, Y., Xu, Y., Huang, Q., Li, L., & Rao, L. (2023) · Theranostics · doi:10.7150/thno.84665 · Cited by 54
Nanovesicles for Lipid Metabolism Reprogram-Enhanced Ferroptosis and Magnetotherapy of Refractory Tumors and Inhibiting Metastasis with Activated Innate Immunity
Cheng, X.-Q., Xu, J., Cui, Y., Liu, J., Chen, Y., He, C., Cui, L., Liu, Y., Song, B., Gong, C., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c16981 · Cited by 55
Multifunctional Nanocarrier Drug Delivery Systems: From Diverse Design to Precise Biomedical Applications
Zhu, Y., He, M., Lin, C., Ma, W., Ai, Y., Wang, J., & Liang, Q. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502178 · Cited by 61
Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges
Xu, L., Cao, Y., Ya, X., Li, R., & Xu, X. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300238 · Cited by 54
Neutrophil-like pH-responsive pro-efferocytic nanoparticles improve neurological recovery by promoting erythrophagocytosis after intracerebral hemorrhage
Fan, L., Jin, L., Tang, T., Zheng, Y., Chen, Z., Lin, H., Ding, C., Wang, T., Chen, H., Guo, Y., et al. (2023) · Theranostics · doi:10.7150/thno.90370 · Cited by 51
“Extractive plasma membranes inherited the surface structure and protein profile of the original cells, and excelled at interacting with complicated biological environments to avoid unexpected immune response [43].”
Liposomes-enabled cancer chemoimmunotherapy
Zhang, L., Shi, J., Zhu, M., Huang, Y., Lu, Q., Sun, P., Chen, H., Lai, X. P., & Fang, C. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122801 · Cited by 53
Self-citation
Intelligent Biomaterialomics: Molecular Design, Manufacturing, and Biomedical Applications
Yi, Y., An, H., & Wang, H. (2023) · Advanced Materials · doi:10.1002/adma.202305099 · Cited by 52
Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer
Zhang, W., Fan, Y., Zhang, J., Shi, D., Yuan, J., Ashrafizadeh, M., Li, W., Hu, M., El‐Aty, A. M. A., Hacımüftüoğlu, A., et al. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101005 · Cited by 52
Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity
Li, Y., Guo, Y., Zhang, K., Zhu, R., Chen, X. S., Zhang, Z., & Yang, W. (2023) · Advanced Science · doi:10.1002/advs.202306580 · Cited by 50
Swarm Autonomy: From Agent Functionalization to Machine Intelligence
Wang, Y., Chen, H., Xie, L., Liu, J., Zhang, L., & Yu, J. (2024) · Advanced Materials · doi:10.1002/adma.202312956 · Cited by 53
Self-citation
Nanomedicine for T‐Cell Mediated Immunotherapy
Li, F., Ouyang, J., Chen, Z., Zhou, Z., Essola, J. M., Ali, B., Wu, X., Zhu, M., Guo, W., & Liang, X. (2023) · Advanced Materials · doi:10.1002/adma.202301770 · Cited by 51
Tumor Microenvironment-Activated In Situ Synthesis of Peroxynitrite for Enhanced Chemodynamic Therapy
Li, B., Wu, C., Li, Z., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c10012 · Cited by 49
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
Huang, P., Deng, H., Wang, C., Zhou, Y., & Chen, X. S. (2023) · Advanced Materials · doi:10.1002/adma.202307822 · Cited by 53
From bench to bedside: Platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery
Safdar, A., Wang, P., Muhaymin, A., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.013 · Cited by 48
Iron oxide nanoparticles in magnetic drug targeting and ferroptosis-based cancer therapy
Shubhra, Q. T. H. (2023) · Medical Review · doi:10.1515/mr-2023-0029 · Cited by 47
“However, similar to other NP types, it is crucial to coat the bare surface of IO NPs (for example, with polymers or cell membranes) to prevent opsonization and aggregation, and evade macrophage uptake, so that they can reach the tumor site (Figure 1A) [2].”
Background
The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications
Mao, Z., Wang, B., Zhang, T., & Cui, B. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06265-2 · Cited by 51
Engineered Cell Membrane‐Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation
Ma, Y., Yi, J., Ruan, J., Ma, J., Yang, Q., Zhang, K., Zhang, M., Zeng, G., Jin, L., Huang, X., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400514 · Cited by 48
Engineered platelets as targeted protein degraders and application to breast cancer models
Chen, Y., Pal, S., Li, W., Liu, F., Yuan, S., & Hu, Q. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02494-8 · Cited by 49
Synthetic Biology‐Based Engineering Cells for Drug Delivery
Yi, W., Hu, S., Qian, X., Yan, W., & Li, Y. (2025) · Exploration · doi:10.1002/exp.20240095 · Cited by 49
“Due to the excellent biocompatibility of cell membranes, biomimetic nanomedicines made with cell membrane-encapsulated drug-carrying nanoparticles can effectively avoid clearance by the reticuloendothelial system, thereby extending their circulation time in the bloodstream [258].”
Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges
Jiang, Y., Yan, C., Li, M., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135072 · Cited by 46
Overcoming cancer therapy resistance: From drug innovation to therapeutics
Wei, J., Lu, M., Wei, T., Fleishman, J. S., Yu, H. J., Chen, X.-L., Kong, X.-T., Sun, S., Li, N., Yang, Y., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101229 · Cited by 53
Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Chu, Z., Wang, W., Zheng, W., Fu, W., Wang, Y., Wang, H., & Qian, H. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00636d · Cited by 45
Biological self-protection inspired engineering of nanomaterials to construct a robust bio-nano system for environmental applications
Xu, N., Zhang, X., Guo, P.-C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp2179 · Cited by 45
Bio-barrier-adaptable biomimetic nanomedicines combined with ultrasound for enhanced cancer therapy
Guo, J., Pan, X., Wu, Q., Li, P., Wang, C., Liu, S., Zhang, H., Huang, Z., Mou, X., Liu, H., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02217-8 · Cited by 50
“63 This approach exploits inherent biological functions, including homotypic targeting and immune evasion, representing a signi ﬁ cant step toward precision medicine.”
Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma
Xu, Y., Du, L., Han, B., Wang, Y., Fei, J., Xia, K., Zhai, Y., & Yu, Z. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02016-9 · Cited by 44
“Examination of OPM properties on BPQDs‐DOX@OPM The cellular hybrid membrane-encapsulated nanoparticles consist of two main parts: nanocarrier core and surface cell membrane shell structure [32].”
Background
The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 studies
Yu, P., Zhu, C., You, X., Gu, W., Wang, X., Wang, Y., Bu, R., & Wang, K. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06837-w · Cited by 45
“Unfortunately, patients with resistant tumors often have a poor prognosis [4], presenting an urgent need for new clinical trials to determine more effective treatment strategies for advanced patients.”
Targeted photodynamic therapy: enhancing efficacy through specific organelle engagement
Tao, J., Yuan, Z., & Zhou, M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1667812 · Cited by 44
Lipid Nanoparticle-Based Delivery SystemA Competing Place for mRNA Vaccines
Zhang, X., Li, Y., & Zhou, Z. (2024) · ACS Omega · doi:10.1021/acsomega.3c08353 · Cited by 43
Kidney targeting peptide-modified biomimetic nanoplatforms for treatment of acute kidney injury
Huang, Z., Chun, C., & Li, X. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.042 · Cited by 42
Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders
Chu, R., Wang, Y., Kong, J., Pan, T. S., Yang, Y., & He, J. F. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02766j · Cited by 49

Authors: Fang, R. H., Gao, W., & Zhang, L.
Affiliations: University of California San Diego (US)
Corresponding author: Zhang, Liangfang
ORCID: Fang, Ronnie H.
Gao, Weiwei
Zhang, Liangfang
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2022-10-28
Volume: 20
Issue: 1
Pages: 33-48
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/s41571-022-00699-x
OpenAlex: W4307475977
Semantic Scholar: aad18fe7d6405872bceb0dd4451cf81880d894d6
Cited by: 980
References: 162
Citations by year: 2026: 249 · 2025: 320 · 2024: 281 · 2023: 129 · 2022: 1
FWCI: 12.57
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA200574)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: cell membrane-coated nanoparticles, anticancer drug delivery, tumor targeting, biomimetic nanocarriers, immune evasion, phototherapy, cancer immunotherapy, nanoparticle biocompatibility
MeSH terms: Cell Membrane, Pharmaceutical Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting drugs to tumours using cell membrane-coated nanoparticles

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks